Hiromasa Morikawa

6.7k citations
35 papers · 2.3k indexed · 2 hit papers · h-index 15
Topics
Cancer, Hypoxia, and Metabolism (8 papers)T-cell and B-cell Immunology (6 papers)Tracheal and airway disorders (4 papers)

In The Last Decade

Hiromasa Morikawa

32 papers receiving 2.2k citations

Hit Papers

PD-1 + regulatory T cells amplified by PD-1...201220262016202120192012200400600

Peers

Hiromasa Morikawa
Comparison fields: 5 of 97
  • Immunology 1.4k
  • Oncology 910
  • Molecular Biology 550
  • Cancer Research 281
  • Pulmonary and Respiratory Medicine 222
Replace Scott B. Lovitch with:
Scott B. Lovitch United States
Vincent Hurez United States
Linhua Zou United States
Sylvain Fisson France
Filip Bednar United States
Aadel A. Chaudhuri United States
Bogdan Luca United States
Jenna M. Sullivan United States
Ping‐Ying Pan United States
Husain Sattar United States
Hiromasa Morikawa relative to Scott B. Lovitch United States Scott B. Lovitch's profile →
Citations per field
00.5×1.5×2.0×
Scott B. Lovitch · 1×
Citations per year

Countries citing papers authored by Hiromasa Morikawa

Since Specialization
Citations

This map shows the geographic impact of Hiromasa Morikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromasa Morikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromasa Morikawa more than expected).

Fields of papers citing papers by Hiromasa Morikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromasa Morikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromasa Morikawa. The network helps show where Hiromasa Morikawa may publish in the future.

Co-authorship network of co-authors of Hiromasa Morikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Hiromasa Morikawa. A scholar is included among the top collaborators of Hiromasa Morikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiromasa Morikawa. Hiromasa Morikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 4
3 18
4 12
5 14
6 11
7 62
8
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancerbreakdown →
692
9 84
10
T Cell Receptor Stimulation-Induced Epigenetic Changes and Foxp3 Expression Are Independent and Complementary Events Required for Treg Cell Developmentbreakdown →
570
11 9
12 11
13 2
14 0
15 1
16 1
17 14
18 2
19 1
20 2

About Hiromasa Morikawa

Hiromasa Morikawa is a scholar working on Microbiology, Biological Psychiatry and Cancer Research, having authored 35 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (8 papers), T-cell and B-cell Immunology (6 papers) and Tracheal and airway disorders (4 papers). The work is most often cited by research in Immunology (1.4k citations), Oncology (910 citations) and Cancer Research (281 citations). Hiromasa Morikawa has collaborated with scholars based in Japan, Sweden and United Kingdom. Frequent co-authors include Shimon Sakaguchi, Atsushi Tanaka, Motonao Osaki, Hiroyoshi Nishikawa, Shota Fukuoka, Takahiro Kamada, Yoshiaki Nakamura, Yosuke Togashi, Akihito Kawazoe and Akinori Sasaki. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026